PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, USA.\', \'Department of Biological Sciences, Northern Arizona University, Flagstaff, Arizona, USA.\', \'Allarity Therapeutics, Hørsholm, Denmark.\', \'Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, USA ctfrench@nau.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • e03495-2010.1128/mBio.03495-20
?:doi
?:hasPublicationType
?:journal
  • mBio
is ?:pmid of
?:pmid
?:pmid
  • 33468703
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.106
?:rankingScore_hIndex
  • 71
is ?:relation_isRelatedTo_publication of
?:title
  • Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses In Vitro.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all